STZ
50
5
RCL
76
7
PHM
61
-3
ADM
28
3
KHC
36
5
NEE
46
-4
MPC
46
-6
CB
58
3
WAT
47
-2
SRCL
33
2
MTB
55
7
COST
53
3
NKE
34
3
ROP
45
-2
ESS
50
2
PFE
21
3
BMY
51
-4
GE
65
4
NTRS
50
8
FITB
55
3
STZ
50
5
RCL
76
7
PHM
61
-3
ADM
28
3
KHC
36
5
NEE
46
-4
MPC
46
-6
CB
58
3
WAT
47
-2
SRCL
33
2
MTB
55
7
COST
53
3
NKE
34
3
ROP
45
-2
ESS
50
2
PFE
21
3
BMY
51
-4
GE
65
4
NTRS
50
8
FITB
55
3
Financhill
Back

Brainstorm Cell Therapeutics Vs. Outlook Therapeutics Industry Stock Comparison

Sell
8

BCLI
Brainstorm Cell Therapeutics

Last Price:
2.23
Seasonality Move:
-7.58%
Sell
22

OTLK
Outlook Therapeutics

Last Price:
5.24
Seasonality Move:
-4.13%
Sell
8
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $2.34. The Score for BCLI is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Outlook Therapeutics (OTLK) is a Sell

Is Outlook Therapeutics a Buy, Sell or Hold?

  • The current Outlook Therapeutics [OTLK] share price is $5.23. The Score for OTLK is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $2.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.

OTLK Stock Price Chart

What is Outlook Therapeutics's stock price today?

  • The Outlook Therapeutics share price today is $5.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTLK is experiencing selling pressure, which indicates risk of future bearish movement.

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 24.28 Sell
Chaikin Money Flow: -18150 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.17 - 4.27) Sell
Bollinger Bands (100): (3.91 - 6.79) Sell

OTLK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 29.73 Sell
Chaikin Money Flow: -185378 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.36 - 7.22) Sell
Bollinger Bands (100): (6.42 - 8.12) Sell

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.15 Sell
20-day SMA: 3.59 Sell
50-day SMA: 4.27 Sell
200-day SMA: 5.74 Sell
8-day EMA: 3 Sell
20-day EMA: 3.5 Sell
50-day EMA: 4.22 Sell
200-day EMA: 7.23 Sell

OTLK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.38 Sell
20-day SMA: 6 Sell
50-day SMA: 6.88 Sell
200-day SMA: 7.78 Sell
8-day EMA: 5.41 Sell
20-day EMA: 5.9 Sell
50-day EMA: 6.63 Sell
200-day EMA: 8.73 Sell

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.55 per share, and an increase next year of $0.08 per share.

Outlook Therapeutics Earnings Growth & OTLK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Outlook Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):